The clinical presentation and management of carcinoid heart disease

被引：33

作者：

Dobson, R. ^{[1
,5
]}

Burgess, M. I. ^{[1
,2
]}

Pritchard, D. M. ^{[3
,4
]}

Cuthbertson, D. J. ^{[1
,5
]}

机构：

[1] Aintree Univ Hosp NHS Fdn Trust, Neuroendocrine Tumour Grp, Liverpool L9 7AL, Merseyside, England

[2] Aintree Univ Hosp NHS Fdn Trust, Dept Cardiol, Liverpool L9 7AL, Merseyside, England

[3] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3GE, Merseyside, England

[4] Royal Liverpool Univ Hosp, Neuroendocrine Tumour Grp, Liverpool L7 8XP, Merseyside, England

[5] Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Liverpool L69 3GA, Merseyside, England

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 173卷 / 01期

关键词：

Carcinoid heart disease; Valve surgery; Management; ENETS CONSENSUS GUIDELINES; BRAIN NATRIURETIC PEPTIDE; NEUROENDOCRINE-TUMORS; CARDIAC-SURGERY; VALVE-REPLACEMENT; HEPATIC RESECTION; GROWTH-FACTOR; ECHOCARDIOGRAPHY; DIAGNOSIS; OUTCOMES;

D O I：

10.1016/j.ijcard.2014.02.037

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Carcinoid heart disease is a major cause of morbidity and mortality in patients with metastatic neuroendocrine tumours (NETs). Although cases of carcinoid syndrome and severe carcinoid heart disease requiring urgent intervention are well described, many patients with significant carcinoid heart disease may have insidious symptoms or even be asymptomatic. As haemodynamically significant carcinoid heart disease may be clinically silent, specific and individualised considerations must be made as to the most appropriate clinical criteria and time point at which surgical valve replacement should be undertaken in patients with carcinoid heart disease. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：29 / 32

页数：4

共 50 条

[31] Carcinoid heart disease
Anderson, AS
Krauss, D
Korcarz, C
Lang, RM
CIRCULATION, 1996, 93 (01) : 187 - 188
[32] Carcinoid heart disease
Bernheim A.M.
Connolly H.M.
Patricia P.
Current Treatment Options in Cardiovascular Medicine, 2007, 9 (6) : 482 - 489
[33] Carcinoid heart disease
Silvia Di Luzio
Vera H. Rigolin
Current Treatment Options in Cardiovascular Medicine, 2000, 2 (5) : 399 - 406
[34] Carcinoid heart disease
Gaos, CM
Nasser, MM
Wilansky, S
CIRCULATION, 1997, 95 (05) : 1346 - 1346
[35] Carcinoid heart disease
Hassan, Saamir A.
Banchs, Jose
Iliescu, Cezar
Dasari, Arvind
Lopez-Mattei, Juan
Yusuf, Syed Wamique
HEART, 2017, 103 (19) : 1488 - 1495
[36] CARCINOID HEART DISEASE
COSH, J
CATES, JE
PUGH, DW
BRITISH HEART JOURNAL, 1959, 21 (03): : 369 - 380
[37] CARCINOID-TUMORS - THE RELATIONSHIP BETWEEN CLINICAL PRESENTATION AND THE EXTENT OF DISEASE
MACGILLIVRAY, DC
SYNDER, DA
DRUCKER, W
REMINE, SG
SURGERY, 1991, 110 (01) : 68 - 72
[38] Carcinoid heart disease
do Rosario, Ingrid
Andrade, Maria Joao
Arroja, Isabel
Placido, Ana
Mendes, Miguel
REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (01) : 59 - 60
[39] Carcinoid heart disease
Bhattacharyya, Sanjeev
Davar, Joseph
Dreyfus, Gilles
Caplin, Martyn E.
CIRCULATION, 2007, 116 (24) : 2860 - 2865
[40] Carcinoid heart disease
Bernheim, Alain M.
Connolly, Heidi M.
Hobday, Timothy J.
Abel, Martin D.
Pellikka, Patricia A.
PROGRESS IN CARDIOVASCULAR DISEASES, 2007, 49 (06) : 439 - 451

← 1 2 3 4 5 →